BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25664610)

  • 1. HIV-1 induced nuclear factor I-B (NF-IB) expression negatively regulates HIV-1 replication through interaction with the long terminal repeat region.
    Vemula SV; Veerasamy R; Ragupathy V; Biswas S; Devadas K; Hewlett I
    Viruses; 2015 Feb; 7(2):543-58. PubMed ID: 25664610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
    Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-interacting protein inhibits HIV-1 infection and regulates viral latency.
    Li C; Kuang WD; Qu D; Wang JH
    Biochem Biophys Res Commun; 2016 Jun; 475(2):161-8. PubMed ID: 27181351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSP70 binding protein 1 (HspBP1) suppresses HIV-1 replication by inhibiting NF-κB mediated activation of viral gene expression.
    Chaudhary P; Khan SZ; Rawat P; Augustine T; Raynes DA; Guerriero V; Mitra D
    Nucleic Acids Res; 2016 Feb; 44(4):1613-29. PubMed ID: 26538602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some mechanisms of FLIP expression in inhibition of HIV-1 replication in Jurkat cells, CD4+ T cells and PBMCs.
    Tan J; Wang X; Devadas K; Zhao J; Zhang P; Hewlett I
    J Cell Physiol; 2013 Dec; 228(12):2305-13. PubMed ID: 23696271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-κB Signaling.
    Wang H; Liu Y; Huan C; Yang J; Li Z; Zheng B; Wang Y; Zhang W
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
    Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
    J Virol; 2018 May; 92(9):. PubMed ID: 29491162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
    Krishnan V; Zeichner SL
    J Virol; 2004 Sep; 78(17):9458-73. PubMed ID: 15308739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of active HIV-1 replication by NF-kappaB inhibitor DHMEQ.
    Miyake A; Ishida T; Yamagishi M; Hara T; Umezawa K; Watanabe T; Horie R
    Microbes Infect; 2010 May; 12(5):400-8. PubMed ID: 20172044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.
    Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD
    Retrovirology; 2018 Oct; 15(1):67. PubMed ID: 30286764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.
    Manganaro L; Pache L; Herrmann T; Marlett J; Hwang Y; Murry J; Miorin L; Ting AT; König R; García-Sastre A; Bushman FD; Chanda SK; Young JA; Fernandez-Sesma A; Simon V
    J Virol; 2014 Jul; 88(13):7528-40. PubMed ID: 24760882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NF-κB-dependent HIV-1 replication by the marine natural product bengamide A.
    Tietjen I; Williams DE; Read S; Kuang XT; Mwimanzi P; Wilhelm E; Markle T; Kinloch NN; Naphen CN; Tenney K; Mesplède T; Wainberg MA; Crews P; Bell B; Andersen RJ; Brumme ZL; Brockman MA
    Antiviral Res; 2018 Apr; 152():94-103. PubMed ID: 29476895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site.
    Hashemi FB; Barreto K; Bernhard W; Hashemi P; Lomness A; Sadowski I
    J Virol; 2016 Jun; 90(11):5302-14. PubMed ID: 26984732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
    Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
    mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.
    Stoszko M; De Crignis E; Rokx C; Khalid MM; Lungu C; Palstra RJ; Kan TW; Boucher C; Verbon A; Dykhuizen EC; Mahmoudi T
    EBioMedicine; 2016 Jan; 3():108-121. PubMed ID: 26870822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression.
    Coiras M; López-Huertas MR; Rullas J; Mittelbrunn M; Alcamí J
    Retrovirology; 2007 Aug; 4():56. PubMed ID: 17686171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct.
    Muto NF; Martinand-Mari C; Adelson ME; Suhadolnik RJ
    J Virol; 1999 Nov; 73(11):9021-8. PubMed ID: 10516008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds.
    Barbeau B; Bernier R; Dumais N; Briand G; Olivier M; Faure R; Posner BI; Tremblay M
    J Biol Chem; 1997 May; 272(20):12968-77. PubMed ID: 9148903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.